Oral Prednisolone Effect on Cancer WHO Stepladder Analgesia Protocol

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

November 15, 2019

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions
Steroid Anlgesia in Cancer Pain
Interventions
DRUG

Oral tablet

Patients will be allocated as single group and will take oral prednisolone (sulopride10 mg) single dose every two days for 4 successive weeks then the next two weeks as washout period (stop dosing gradually by taking 5 mgs for 3 successive dosing every 2nd day over a week, then stop the oral steroid drug totally over the 2nd week of the washout period. The second period of the study will start by taking the oral prednisolone (sulopride10 mg) every fourth day for the next 4 weeks after which the patient will get another washout two weeks period (stop dosing gradually 5 mg for 3 successive dosing every 4th day then stop the drug totally).

Trial Locations (1)

35516

Oncolgy Center, Mansoura University,, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT04162379 - Oral Prednisolone Effect on Cancer WHO Stepladder Analgesia Protocol | Biotech Hunter | Biotech Hunter